I definitely hope that newer formulations with various advantages are released. In fact it seems like they are already on the way with Tirzepatide (a GLP-1 and

I definitely hope that newer formulations with various advantages are released. In fact it seems like they are already on the way with Tirzepatide (a GLP-1 and GIP analogue). More distant are GLP-1/GIP/Glucagon agonists, which are likely to be more effective still. However I doubt that Novo's competitors which are researching this drug will kindly wait for Novo's patent to run out before releasing them.